Every July,JDRF sets ambitious goals for progress in type 1 diabetes (T1D) research in the coming year because you, our supporters, inspire us to aim higher.Thank you. Your generosity makes our strategic plan possible and propels us toward our shared vision of a world without T1D.
Because of members of the JDRF family like you, we can report real progress in T1D research that will impact millions of people living with thedisease. Together, we can celebrate achievements you helped make possible this past year such as:
Beta cell encapsulation therapy that can create insulin independence forup to two years is moving to human safety testing.
Current studies show potentialin a drug that can slow or stop kidney disease, a serious complication of T1D.
At-home testing of artificial pancreas systems that will maintain tighter blood-glucose control automatically has begun.